banner
Reference Listed Drugs
Pralsetinib Capsules Reference Listed Drug

Pralsetinib Capsules Reference Listed Drug

GAVRETO, also known as pralsetinib, is used to treat certain cancers caused by abnormal RET genes. For R&D purposes only.

Product Details

* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.

 

Generic name Pralsetinib Capsules
Trade name GAVRETO/普吉华
Specification 100mg
Main ingredients Pralsetinib
Dosage Form Capsule
MA Holder Genentech, Inc. (A Member of the Roche Group)
Category Reference Listed Drugs (RLDs)

 

Indications:
GAVRETO is used to treat certain cancers caused by abnormal rearranged during transfection (RET) genes in:
1. adults with non-small cell lung cancer (NSCLC) that has spread;
2. adults and children 12 years of age and older with advanced medullary thyroid cancer (MTC) or MTC that has spread who require a medicine by mouth or injection (systemic therapy);
3. adults and children 12 years of age and older with advanced thyroid cancer or thyroid cancer that has spread who require a medicine by mouth or injection (systemic therapy) and who have received radioactive iodine and it did not work or is no longer working.

 

For more details, pls contact Janney:

Email: tosun-global@upharm.cn

Wechat/Whatsapp:(+86)18922120575

Hot Tags: pralsetinib capsules reference listed drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Agomelatine Tablets, Argatroban Injection, Olanzapine Tablets, AdapaleneGel, Phenytoin Sodium Tablets, Alfacalcidol Soft Capsules

Send Inquiry
Verification Code: